Alpha-1 antitrypsin deficiency: current therapy and emerging targets.

Oisín F McElvaney,Daniel D Fraughen,Oliver J McElvaney,Tomás P Carroll,Noel G McElvaney

Expert review of respiratory medicine（2023）

Cited 0|Views19

No score

Abstract

With a relatively small population able to participate in clinical studies, increased awareness and diagnosis of AATD is urgently needed. Better, more sensitive clinical parameters will assist in the generation of acceptable and robust evidence of therapeutic effect for current and emerging treatments.

Translated text

Key words

Alpha1 antitrypsin deficiency,COPD,cirrhosis,emphysema,gene editing,gene therapy,panniculitis,protein folding,siRNA

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined